started · updated
Healthcare access and oncology advancements in Poland and the US
Medical experts are highlighting critical gaps and advancements in cancer and neurodegenerative disease treatments. In Poland, the B. 90 drug program for Parkinson's disease faces significant accessibility issues. Only 721 patients are currently utilizing the program, with entire regions like Lubelskie and Warmian-Masurian lacking dedicated medical centers. Experts note that hospitals often limit new patient enrollments due to financial risks, as the National Health Fund (NFZ) may only cover half of the operational costs.
Regarding oncology, advancements in immunotherapy and targeted therapies have significantly improved survival rates. In the United States, the five-year relative survival rate for all cancers has increased to 70 percent, up from 49 percent in the mid-1970s. Specific improvements have been noted in multiple myeloma, liver cancer, and lung cancer.
In Poland, a new national lung cancer screening program using low-dose computed tomography (LDCT) is set to launch in October. Experts state that LDCT can reduce the risk of death by 20 percent generally and by 40 percent for women. While the B. 6 drug program for lung cancer is well-established, specialists emphasize the need for more advanced therapies, such as those targeting MET gene mutations and RET rearrangements, to keep pace with medical progress.
Entities
American Cancer Society · Lubelskie Voivodeship · National Health Fund · National Institute of Oncology · Warmian-Masurian Voivodeship
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] The five-year relative survival rate for all cancers in the United States has risen to 70 percent from 49 percent in the mid-1970s. biznes.newseria.pl
- [○ 1 SOURCE] There are no medical centers conducting the B. 90 program in the Lubelskie and Warmian-Masurian voivodeships. www.mzdrowie.pl
- [○ 1 SOURCE] Low-dose computed tomography (LDCT) screening reduces the risk of death by 20 percent overall and by 40 percent for women. www.rynekzdrowia.pl
- [○ 1 SOURCE] Hospitals face financial risks because the National Health Fund (NFZ) often covers only half of the costs for running drug programs. www.mzdrowie.pl
- [○ 1 SOURCE] Only 721 patients are currently utilizing the B. 90 drug program. www.mzdrowie.pl